Cargando…

The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience

Congenital adrenal hyperplasia (CAH) occurs due to enzyme defects in adrenal steroidogenesis. The 21-hydroxylase deficiency accounts for 90–95% of cases, triggering accumulation of 17-hydroxyprogesterone (17-OHP). Early diagnosis through neonatal screening allows adequate treatment and reduced morta...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Castro, Simone Martins, Wiest, Paloma, Spritzer, Poli Mara, Kopacek, Cristiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620452/ https://www.ncbi.nlm.nih.gov/pubmed/37902057 http://dx.doi.org/10.1530/EC-23-0162

Ejemplares similares

SAT-098 The Impact of 17-OHP Cutoffs Determination in a Public Newborn Screening Program for Congenital Adrenal Hyperplasia in Southern Brazil: A Three Years’ Experience
por: Kopacek, Cristiane, et al.
Publicado: (2020)

Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants
por: Kopacek, Cristiane, et al.
Publicado: (2017)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia
por: Al‐Kofahi, Mahmoud, et al.
Publicado: (2020)

A pilot study on the effect of three hydrocortisone dosing regimen on 17 hydroxyprogesterone levels in patients with congenital adrenal hyperplasia
por: Salud, Josephine Leiya Marie F, et al.
Publicado: (2013)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

Diurnal salivary androstenedione and 17‐hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022)

A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
por: Besci, Özge, et al.
Publicado: (2022)

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
por: Stachanow, Viktoria, et al.
Publicado: (2023)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)
por: Chesover, Alexander, et al.
Publicado: (2019)

Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
por: Bialk, Eric R., et al.
Publicado: (2019)

Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
por: Navardauskaitė, Rūta, et al.
Publicado: (2021)

Relationships of Basal Level of Serum 17-Hydroxyprogesterone with that of Serum Androstenedione and Their Stimulated Responses to a Low Dose of ACTH in Young Adult Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kang, Min Jae, et al.
Publicado: (2011)

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
por: de Miranda, Mirela Costa, et al.
Publicado: (2021)

Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening
por: Banaszak-Ziemska, Magdalena, et al.
Publicado: (2021)

Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
por: Carsote, Mara, et al.
Publicado: (2023)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

THU256 Prevalence And Risk Factors Associated With Diabetes Mellitus Among Middle Aged Women In Southern Brazil: A Population Based Study
por: Oppermann, Karen, et al.
Publicado: (2023)

Brain White Matter Abnormality in a Newborn Infant with Congenital Adrenal Hyperplasia
por: Kaga, Akimune, et al.
Publicado: (2013)

Results from 28 Years of Newborn Screening for Congenital Adrenal Hyperplasia in Sapporo
por: Morikawa, Shuntaro, et al.
Publicado: (2014)

Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020)

Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia
por: Grosse, Scott D., et al.
Publicado: (2020)

Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study
por: Colpani, Verônica, et al.
Publicado: (2014)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Congenital lipoid adrenal hyperplasia
por: Kim, Chan Jong
Publicado: (2014)

Measurement of Serum 17α-hydroxyprogesterone in Newborn Infants by Stable Isotope Dilution—Gas Chromatography/Mass Spectrometry
por: Homma, Keiko, et al.
Publicado: (2009)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020)

Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil
por: Gilban, Daniel Luis Schueftan, et al.
Publicado: (2014)

Results from 28 years of newborn screening for congenital adrenal hyperplasia in Sapporo City
por: Ishizu, Katsura, et al.
Publicado: (2013)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Nonvirilized Genitalia in 3 Female Newborns With the Salt-Wasting Congenital Adrenal Hyperplasia Phenotype
por: Yauch, Lauren, et al.
Publicado: (2020)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021)

Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009)

Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
por: Flint, Jennifer L., et al.
Publicado: (2013)

Giant Bilateral Adrenal Myelolipoma with Congenital Adrenal Hyperplasia
por: Al-Bahri, S., et al.
Publicado: (2014)

Management of the Adult with Congenital Adrenal Hyperplasia
por: Auchus, Richard J.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uduqh32ss13rfbu9fv483sg2f4